ReviewJournal for immunotherapy of cancer2025

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials.

Christopher R Cabanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.